SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-14-000431
Filing Date
2014-02-07
Accepted
2014-02-07 16:15:09
Documents
2
Period of Report
2014-02-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-02072014_040201.htm 8-K 13257
2 ex3-02072014_040202.htm EX-3 97111
  Complete submission text file 0001415889-14-000431.txt   111613
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54014 | Film No.: 14584502
SIC: 2834 Pharmaceutical Preparations